Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
RenovoRx prices initial public offering
RenovoRx announced the pricing of its initial public offering of 1,850,000 units at $9.00 per unit. The shares were expected to begin trading on Nasdaq on August 26, 2021, and the offering was expected to close on August 30, subject to customary closing conditions.
2020
RenovoRx receives sixth U.S. patent
RenovoRx announced that the U.S. Patent and Trademark Office issued it a patent covering its Trans-Arterial Micro-Perfusion therapeutic method.